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Background: Aim of this study was to evaluate the clinical impact of the culprit plaque features assessed by Optical Coherence Tomography (OCT) in patients with Acute Coronary Syndrome (ACS).
Methods and Results: The OCT-FORMIDABLE register enrolled retrospectively all consecutive patients who perform OCT on culprit plaque in patients with ACS in 9 centres. The primary endpoint was the correlation of culprit plaque characteristics at OCT with incidence of major adverse cardiovascular events (MACEs, defined as the composite of death from cardiac causes, non- fatal MI, clinically driven target vessel revascularization). The evaluation of the impact of plaque characteristics on therapy efficacy was the secondary endpoint  
285 patients were included in the study. Mean age was 60.412.8 years old, 20.4% of the patients were of female gender. Main clinical presentation was ST-elevation myocardial infarction (STEMI, 49.8%). At OCT analysis culprit plaque rupture (CPR) was present in 65.3% of cases, 61.1% presented thin cap fibro-atheroma, while 33.8% presented necrotic core with macrophage infiltrations (NCMI). During follow-up (11.713.7 months) 12.3% of the patients experienced MACEs.
At the multivariate analysis presence of CPR (HR 3.8, 1.5-10, p<0.01) and NCMI (HR 3.2, 1.5-6.5, p<0.01) were independent predictors for MACEs while the implantation of a second generation drug eluting stent (DESs, HR 0.3, 0.1-0.6, p<0.01) and dual antiplatelet therapy with prasugrel or ticagrelor at discharge (HR 0.4, 0.1-0.9, p=0.03) were protective.  The protective impact of second generation drug eluting stents and of new antiaggregant drugs was reported only in patients with CPR while in patients without  any of the baseline clinical or procedural features impacted on MACEs.
Conclusions: CPR and the presence of NCMI are independent predictors of worse outcome. Patients with CPR seem to benefit more of an intensive therapy, both from a pharmacological and interventional point of view. (NCT02486861)



























Acute coronary syndrome (ACS) is the most common reason for cardiac hospitalization in the western world and its prevalence is constantly increasing in most Eastern European countries and United States of America. Approximately 70% of these patients experience non-ST elevation myocardial infarction (NSTEMI) (1,2). 
ACS pathophysiology deeply differs from those of stable patients, mainly due to peculiar features of plaque. Interestingly, most of the lesions triggering an acute ischemic event, usually defined “culprit lesions” are not angiographically severe, but present with mild stenosis (3-7). However, when evaluated at autopsy or with intracoronary imaging, they show often a pro-thrombotic pattern, with thin cap fibroatheroma, soft plaques with necrotic core and thrombus, prone to rupture (5).
On the other side, patients without culprit plaque rupture (CPR) exhibit different mechanisms of instability including thrombus at the site of plaque erosion, or intense vasoconstriction of epicardial arteries or coronary microcirculation dysfunction (6,7). 
In the last years Optical Coherence Tomography (OCT, 8) has emerged as the most accurate instrument for intracoronary evaluation. Due to a resolution of approximately 10-20 µm (8-11) it has been largely exploited in the evaluation and characterization of plaque features, both in stable and acute coronary artery disease (12).  However, despite recent evidences (13), characteristics of culprit plaque in different subset of patients are not well defined and its clinical significance remains unknown. 
The OCT-FORMIDABE (OCT-Features Of moRphology, coMposItion anD instABility of culprit and pLaquE in ACS patients) study is a multicentre registry that enrolled all the patients with acute coronary syndrome undergone to OCT on culprit plaque. 
In this setting, aim of this study was to evaluate by the OCT-FORMIDABLE registry data’s the clinical impact of the culprit plaque features visualised by OCT on major acute cardiovascular events and therapy efficacy in patients with ACS.

Methods
The OCT-FORMIDABLE register included in a retrospective fashion all consecutive patients that perform OCT on culprit and not culprit plaque in any subset in patients with ACS between January 2014 and October 2015 in 9 centres (Web Appendix Table A).
Patients with poor image quality, incomplete pull-back or missing data were excluded. Of note, the choice to perform OCT was left to the operator’s decision.
All patients gave their informed consent, the study was approved by the local Ethics Committee and registered on ClincalTrial.gov (NCT02486861). Clinical and OCT data were recorded in the register according to the dataset as well for medications taken on admission and hospital discharge. For the index admission, diagnosis according to ESC guidelines (STEMI, ST Segment Elevation Myocardial Infarction, NSTEMI Non St Segment and UA Unstable angina) (14).




Invasive treatment and clinical data collection
All STEMI patients were treated with aspirin (300 mg) and clopidogrel (600 mg) or prasugrel (60 mg) or ticagrelor (180 mg) on admission to the Emergency Department. Percutaneous coronary interventions were performed through a radial or femoral access according to operator preference, using a 6 French catheter. A bolus of 5000 IU of heparin was administered. Glycoprotein IIb/IIIa inhibitors were administered after diagnostic angiogram at the start of percutaneous coronary interventions in all patients, as well as manual thrombus aspiration according to operator’s decision.
All patients with NSTE-ACS received aspirin (300 mg, followed by aspirin 100 mg daily) and were treated with a loading dose of clopidogrel (600 mg) or or prasugrel (60 mg) or ticagrelor (180 mg) and fondaparinux or enoxaparin on admission to the Emergency Department according physician’s decision. Use of IIb/IIIa inhibitors was left to operator’s decision.

OCT procedure
A 0.014-inch guidewire was placed distally in the target vessel and an intracoronary injection of 200 µg of nitroglycerin was performed. Frequency domain OCT (FD-OCT) images were acquired by a commercially available system (Web Appendix Table B), which was advanced to the culprit lesion. The FD-OCT run was performed using the integrated automated pullback device at 75 mm/s. In case of STE-ACS patients, OCT was performed after vessel reopening with thrombus aspiration if necessary. During image acquisition, coronary blood flow was replaced by continuous flushing of contrast media directly from the guiding catheter at a rate of 3-4 ml/s with a power injector in order to create a virtually blood-free environment.

OCT image analysis
Optical coherence tomography image analysis was performed offline by two expert investigators who were blinded to the clinical presentation; discordance was resolved by consensus. Culprit lesion was identified by means of angiography, electrocardiographic ST-segment alterations, and/or regional wall motion abnormalities on echocardiographic assessment. 
Plaque rupture was defined as the presence of fibrous cap discontinuity leading to a communication between the inner (necrotic) core of the plaque and the lumen. Plaque rupture included also fibrous cap disruption detected over a calcified plaque characterized by protruding calcification, superficial calcium, and the presence of substantive calcium proximal or distal to the lesion. 
Thin cap fibro atheroma will be defined as cap thickness < 65 nm. Thin cap fibro atheroma at rupture site was recorded. 
Fibrocalcific, fibrotic plaque, lipid component or macrophage infiltration will be defined according to International Working Group for Intravascular Optical Coherence Tomography (IWG-IVOCT). Consensus standards (18).

Clinical Follow-up and, end-points definitions: Clinical follow-up was assessed by clinical visit each 6 months or by phone call. 
The primary endpoint was the correlation of culprit plaque OCT characteristics with incidence of major adverse cardiovascular events (MACEs defined as the composite of death from cardiac causes, non- fatal MI, clinically driven target vessel revascularization (TVR), or re-hospitalization due to unstable or progressive angina according to Braunwald Unstable Angina Classification).
Secondary endpoint was the evaluation of the impact of plaque characteristics on therapy efficacy, according to CPR and NCMI.

Sample size calculation
he recent paper of Niccoli et al (16) showed a percentages of plaque rupture of 60% in ACS. According to the paper of Pedruzzi et al (17), at least 100 patients are needed to evaluate independent predictive power of clinical presentation (STEMI vs NSTEMI vs UA), diabetes mellitus, previous use of aspirin, of statin and age.

Statistical Analysis 






















The registry included 285 patients Baseline clinical and angiographic characteristics are shown in Table n.1. Mean age was 60.412.8 years old, 20.4% of the patients were female, 57.5% hypertensive, 14.4% with insulin dependent diabetes mellitus. Main clinical presentation was ST-elevation myocardial infarction (STEMI, 49.8%) and the left anterior descending was the most frequent culprit artery (62.5%). Second generation drug eluting stents (II generation DESs) were the most used stents (43.9 %), at discharge 99.8% of the patients were treated with dual antiplatelet therapy (DAPT), 89.1% with beta-blockers and 98.6% with statins. During follow up (11.713.7 months) 12.3% of the patients experienced MACEs, mainly driven by re-ACS (7.4%, Figure n. 1).

Optical coherence tomography findings
Optical Coherence tomography data are shown in Table n. 2. Plaque rupture was present in 65.3% of the analysed plaques, mean rupture length was 7.77.1 mm, among these 72% presented TCFA at rupture site. Mean fibrous cap thickness was 145.689.9 m, while TCFA was present in the 61.1% of the patients. Culprit plaques were characterized in the 83.5% by lipid components, 50.9% were fibrous, 33.8% presented necrotic core with macrophage infiltrations.

Predictors of MACEs in the overall population
As shown in Table n. 3 clinical predictors of MACEs at univariate analysis were hyperlipidaemia (HR 1.9, 1.1-3, p=0.05), the use of II generation DESs (HR 0.2, 0.1-0.7, p<0.01) and DAPT with prasugrel of ticagrelor at discharge (HR 0.3, 0.1-0.6, p<0.01). At OCT analysis plaque characteristics predictive for MACEs were the presence of necrotic core with macrophage infiltrations (HR 4.6, 2.2-9.7, p<0.01), TCFA (HR 2.4, 1.1-5.4, p=0.04) and the plaque rupture (HR 2.9, 1.1-7.8, p=0.03). On the other side the presence of a fibro-calcific culprit plaque seemed to be protective (HR 0.4, 0.2-0.9, p=0.05). At the multivariate regression analysis independent predictors for MACEs were the presence of plaque rupture (HR 3.8, 1.5-10, p<0.01), necrotic core (HR 3.2, 1.5-6.5, p<0.01), while the implantation of second generation DESs (HR 0.3, 0.1-0.6, p<0.01) and DAPT with prasugrel or ticagrelor at discharge (HR 0.4, 0.1-0.9, p=0.03) were confirmed to be protective.  At Kaplan-Mayer curve analysis patients with culprit plaque rupture (log-rank p=0.01, Figure n. 2) or with the presence of necrotic core with macrophage infiltration (log-rank p<0.01, Figure n. 3) were associated with a worse outcome.

Clinical predictors of MACEs in patients with plaque rupture and patients with intact fibrous cap population












The present study shows the findings of a large registry of ACS patients based on interpretation of clinical interpretation of OCT images. This approach represents a real life scenario, in which interventional cardiologists make decision based on main OCT findings. We showed that ACS plaque characteristics, in particular the presence of PR and NCMI assessed by OCT, deeply impact not only on outcomes, but further on treatment efficacy.
Clinical cardiovascular risk factors, such as smoke, hypertension and diabetes, are a well know players which impact on atherosclerosis burden (20-22), determining coronary artery stenosis and angina. However, just a limited number of plaques destabilize evolving in ACS. Plaque rupture is the most common substrate of ACS, as suggested both by pathological studies and more recently OCT studies (23). Its pathophysiology is unclear, as shown by Virmani et al (24) the presence of thin-cap fibroatheroma, due to the gradual loss of smooth muscular cells and collagen, degraded by the macrophages, from the fibrous cap, can be assumed by one of the most important markers of plaque prone to rupture.
The presence of signs of plaque instability itself does not explain completely the whole picture. An instable plaque can progress to rupture spontaneously, but in some cases, a temporary increase in emotional or physical stress provides the final triggering of the event. Recognized triggers include physical and sexual activity, anger, anxiety, work stress, earthquakes, war and terror attacks, temperature changes, infections, and cocaine use. The triggering pathways may include activation of the sympathetic nervous system with increased heart rate and blood pressure, leading to plaque rupture, or increased coagulability and platelet reactivity, leading to an accentuated thrombotic response on already ruptured plaques (25).  
This evidences show a sort of triangular relationship between atherosclerotic burden, vulnerable plaque and sympathetic nervous system which leads to the ACS. Previous study, in particular by Niccoli et al. (16) demonstrated that patients with ACS presenting with PR as culprit lesion by OCT had a worse prognosis compared with that of patients with intact fibrous cap (IFC).  Patients with ACS and PR when compared with those not having PR had more frequently TCFA in the entire coronary tree explored and show more frequently positively remodelled plaques with large plaque burden when compared with those having an IFC (26, 27).
Our data confirm this finding, moreover adds a new interesting piece in the puzzle, such as the presence of necrotic core. Patients with the evidence of a NCMI shows a worse outcome. The macrophage infiltration, as said previously, is a specific marker of plaque instability and coronary artery’s inflammation. This finding was not reported before probably because of the higher prevalence of plaque rupture and STEMI in our registry compared with the previous studies. 
An important point to underline is that the plaque rupture and the presence of a necrotic core with macrophage infiltration at the culprit plaque level correlate with major acute cardiovascular events driven by re-ACS and not only with target lesion revascularization as could be expected. A possible explanation is that these two findings are markers of a diffuse coronary artery remodelling, due to the innate immunity activation, with activated monocytes, polymorph nuclear neutrophils, eosinophils, and mast cells not, only at the site of plaque rupture but also in the whole coronary circulation.
This hypothesis could be further confirmed by our second finding. Patients with CPR response differently to the treatment from patients with IFC in term of reduction of MACEs. This underline that probably beside the ACS setting the subordinated pathophysiologic mechanisms are different.
In patients with ACS without CPR mechanisms of intense vasoconstriction of epicardial arteries or of coronary microcirculation (28) are probably more important than in patients with CPR. This could explain why in this sub-population therapy with second generation DESs or new antiplatelet drugs seems to be less effective.




CPR and the presence of NCMI visualized by OCT are independent predictors of worse outcome. Patients with CPR seem to be whom benefit the most of an intensive therapy, in particular by second generation DESs and prasugrel/ticagrelor.

Limitation
Our study has several limitations: firstly, a limited sample size and selection bias. Secondly, each centre used a different OCT platform. Third, was not possible to assess statins impact on plaque rupture due to the high rate of administration at hospital discharge.
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